Employers Get Pressure to Pay for Drugs Like Wegovy
Eli Lilly and Novo Nordisk representatives get face time with companies in hopes they will cover their weight-loss drugs.
Read more at The Wall Street Journal
-
Working people will pay the price of higher taxes for employers
World - Financial Times - October 30 -
Ozempic, Wegovy popularity leads to rise of fake weight loss drugs
Top stories - CBS News - November 9 -
Novo Nordisk Launches Wegovy Weight-Loss Drug in China
Business - The Wall Street Journal - 9 hours ago -
As Workers Head Back to the Office, Some Employers Pay for Workplace Etiquette Tutoring
Business - Inc. - October 25 -
National insurance rise will hit lower-wage parts of UK economy hardest, study shows
Business - Financial Times - October 31 -
How will UK tax rises on private equity’s carried interest work?
Business - Financial Times - October 31 -
‘I felt like a prisoner’: the domestic workers ‘trapped’ by Canberra’s diplomatic employers
World - The Guardian - Yesterday -
Let’s get real about what Labour reforms mean for employers
World - Financial Times - 18 hours ago
More from The Wall Street Journal
-
Energy & Utilities Roundup: Market Talk
Business - The Wall Street Journal - 1 hour ago -
Financial Services Roundup: Market Talk
Business - The Wall Street Journal - 1 hour ago -
Auto & Transport Roundup: Market Talk
Business - The Wall Street Journal - 1 hour ago -
Volkswagen Chooses Rivian's Kjell Gruner to Lead U.S. Business
Business - The Wall Street Journal - 6 hours ago -
New AI Entertainment Studio Gets Backing From Peter Chernin, Andreessen Horowitz
Business - The Wall Street Journal - 8 hours ago
